当前位置: X-MOL 学术Clin. Chim. Acta › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
COX-2 in liver fibrosis.
Clinica Chimica Acta ( IF 3.2 ) Pub Date : 2020-03-14 , DOI: 10.1016/j.cca.2020.03.024
Hu Yang 1 , Yang Xuefeng 2 , Wu Shandong 3 , Xiao Jianhua 4
Affiliation  

As a vital inducible sensor, cyclooxygenase-2 (COX-2) plays an important role in the progress of hepatic fibrogenesis. Activation of hepatic stellate cells (HSCs) in the liver can significantly accelerate the onset and development of liver fibrosis. COX-2 overexpression triggers inflammation that is an important inducer in hepatic fibrosis. Increasing evidence indicates that COX-2 is involved in the main pathogenesis of liver fibrosis, such as inflammation, apoptosis, and cell senescence. Moreover, COX-2 expression is altered in patients and animal models with non-alcoholic fatty liver disease or cirrhosis. These findings suggest that COX-2 has a broad and critical role in the development of liver fibrosis. In this review, we summarize the latest advances in the regulation and signal transduction of COX-2 and its impact on liver fibrosis.

中文翻译:

肝纤维化中的COX-2。

作为重要的诱导型传感器,环氧合酶2(COX-2)在肝纤维化进程中起着重要作用。肝中肝星状细胞(HSC)的激活可以显着加速肝纤维化的发生和发展。COX-2的过表达引发炎症,这是肝纤维化的重要诱因。越来越多的证据表明,COX-2参与了肝纤维化的主要发病机制,例如炎症,细胞凋亡和细胞衰老。而且,在患有非酒精性脂肪肝或肝硬化的患者和动物模型中,COX-2的表达发生了改变。这些发现表明,COX-2在肝纤维化的发展中具有广泛而关键的作用。在这篇综述中,我们总结了COX-2的调控和信号转导及其对肝纤维化的影响的最新进展。
更新日期:2020-03-16
down
wechat
bug